The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting approval to Novo Nordisk India for its proposed update to ...
MiBolsilloColombia on MSN
Medicare: List of 15 commonly used drugs that will be cheaper in 2026
Medicare beneficiaries will see major pricing shifts as federal negotiations reshape how costly prescription drugs are paid ...
Amy Schumer made the bombshell announcement that she is divorcing husband Chris Fischer amid reports of turmoil in their ...
A spokesperson for Novo Nordisk, the manufacturer of Wegovy, said: “Wegovy is indicated for weight management, including ...
YOU may be keen to shed pounds from your waistline with fat jabs, but forking out the monthly bill is less appealing – ...
But even as Ozempic enters India, there is a growing sense globally that Novo may have already lost the obesity drug war to Mounjaro, Eli Lilly’s blockbuster that has become India’s top-selling drug ...
The dramatic stock slump, which puts Novo Nordisk at a historically cheap valuation, reflects investor concern over future sales growth and competition, particularly from rival Eli Lilly & Co.
Novo Nordisk’s blockbuster diabetes drug, Ozempic, was officially launched in India on December 12. Unlike in the US and ...
The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results